Biopharmaceutics & Drug Disposition 1979-01-01

Animal model for investigation of fluphenazine kinetics after administration of long-acting esters.

A C Altamura, R Whelpton, S H Curry

Index: Biopharm. Drug Dispos. 1(2) , 65-72, (1979)

Full Text: HTML

Abstract

A model was developed for studying fluphenazine availability and disposition. Rats were given doses of radioactively labelled esters of fluphenazine by intramuscular injection. Radioactivity excreted in urine, faeces, and expired air was assessed for fluphenazine esters, fluphenazine, and CO2 content. Levels of fluphenazine and its esters were measured in plasma, brain, and muscle (injected and non-injected samples). The data mimicked those obtained in other studies involving the same material given to human subjects, and posed new questions concerning the factors controlling fluphenazine availability when given as 'long-acting' intramuscular injections.


Related Compounds

Related Articles:

Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.

2013-09-01

[Int. Clin. Psychopharmacol. 28(5) , 261-6, (2013)]

Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.

2010-06-01

[Schizophr. Res. 119(1-3) , 153-9, (2010)]

Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy.

1982-03-01

[Acta Paediatr. Scand. 71(2) , 335-8, (1982)]

[Effect of a single dose of some long-acting neuroleptics on the estrus cycle and the mammary gland of the rat].

1979-01-01

[C. R. Seances. Soc. Biol. Fil. 173(4) , 797-806, (1979)]

Neuroleptic malignant syndrome.

1986-03-01

[South. Med. J. 79(3) , 331-6, (1986)]

More Articles...